1-800-567-8911 or
604-682-5050
(Telephone interpreting in over 150 languages available)
Canakinumab
Trade Name:
Ilaris
Manufacturer/Distributor:
Novartis
1-800-363-8883 or medinfo.canada@novartis.com
Classification:
Immunomodulatory agent - selective interleukin-1 beta inhibitor
ATC Class:
L04AC08 canakinumab
Status:
active
Notice of Compliance (yyyy/mm/dd):
2010/02/26
Date Marketed in Canada (yyyy/mm/dd):
2010/05/03
Presentation:
Powder for solution: 150 mg/vial for subcutaneous injection. DIN: 02344939
Comments:
For management of Cryopyrin-Associated Periodic Syndrome in adults and children four year of age and older. This includes patients with Familial Cold Autoinflammatory Syndrome/Familial Cold Urticaria and Muckle-Wells Syndrome.
Back to:
Drug Product Listings 
